Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
AssigneeTripep AB
InventorMatti Sallberg
Life of this patent
Estimating the term…
Abstract
Aspects of the present invention relate to the discovery of a novel hepatitis C virus (HCV) isolate. Embodiments include HCV peptides, nucleic acids encoding said HCV peptides, antibodies directed to said peptides, compositions containing said nucleic acids and peptides, as well as methods of making and using the aforementioned compositions including, but not limited to, diagnostics and medicaments for the treatment and prevention of HCV infection.
Claims11
A purified or isolated nucleic acid comprising at least 200 consecutive nucleotides of the sequence of SEQ. ID. NO.:
- 35 or the complement thereof.
A purified or isolated nucleic acid encoding the amino acid sequence of SEQ. ID. NO.:
- 36.
Dependencies are inferred from the claim text.